SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Drug Development
Two Drugs For Heart Failure Show Mixed Results; Novartis Pharmaceuticals Corporation’s Diovan Should Be Used More Often And Scios Inc.'s Natrecor Should Not Be Used At All, VA Medical Center And Baylor University Research Shows
May 22, 2008
 · 
1 min read
Lone Star Bio
Blood-clotting Protein Modified For People With Hard-to-treat Hemophilia, University of Texas Health Science Center Study
May 22, 2008
 · 
1 min read
Lone Star Bio
Genes For Musical Aptitude In Finnish Families Located, University of Helsinki and Southwest Foundation For Biomedical Research Study
May 20, 2008
 · 
1 min read
Drug Development
New Data Show Benefit Of Finasteride In Preventing Prostate Cancer; Link Between Finasteride And High Grade Prostate Cancer Questioned, University of Texas Health Science Center Study
May 19, 2008
 · 
1 min read
Drug Development
Iressa Shows Promise For Treatment Of Metastatic Breast Cancer When Combined With Hormonal Therapy, University of Texas Study
May 19, 2008
 · 
1 min read
Drug Development
Drug Works Well For Moderate-To-Severe Psoriasis; Ustekinumab Injections Every 3 Months A More Convenient Regimen Than Current Therapies, University of Texas Health Science Center Study
May 19, 2008
 · 
1 min read
Lone Star Bio
New Therapy Kills Human Leukemia Cells in Mice, University of Texas Study
May 19, 2008
 · 
1 min read
Lone Star Bio
Weight-Loss Aids Bought On Internet Might Harm Your Heart; Pills, Supplements Have Potentially Dangerous Ingredients, Lack Warning Labels, St. Luke’s Episcopal Hospital Study Finds
May 16, 2008
 · 
1 min read
Drug Development
Drug Combo of Herceptin and Tykerb Helps Women With Advanced Breast Cancer, Baylor-Sammons Cancer Center Study
May 16, 2008
 · 
1 min read
Lone Star Bio
Molecular ‘Clock’ Could Predict Risk For Developing Breast Cancer, UT Southwestern Medical Center Study
May 14, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
July 1, 2026
 · 
11 min read
Press Releases
Vizient Forecasts 20% Growth in Outpatient Care, 7% in Inpatient Care
June 30, 2026
 · 
3 min read
Press Releases
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
June 30, 2026
 · 
4 min read
Press Releases
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 30, 2026
 · 
1 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
 · 
9 min read
Press Releases
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
 · 
5 min read
Press Releases
Texas Biomed and Flyttr partner to advance next-generation solutions for the invasive New World screwworm
June 29, 2026
 · 
3 min read
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Load More